Camp4 Therapeutics (CAMP) Change in Accured Expenses (2023 - 2026)

Camp4 Therapeutics has reported Change in Accured Expenses for 4 years, with the latest figure at -$1.4 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 50.86% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 230.48% YoY) and the FY2025 annual result came in at $805000.0, down 47.42% from the prior year.
• Change in Accured Expenses slipped to -$1.4 million in Q1 2026 per CAMP's latest filing, from $1.2 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $1.8 million in Q4 2024 and troughed at -$2.8 million in Q1 2025.
• A 4-year average of $152900.0 and a median of $639500.0 in 2023 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses soared 227.58% in 2024, then tumbled 721.88% in 2025.
• Over 4 years, Change in Accured Expenses stood at $562000.0 in 2023, then jumped by 227.58% to $1.8 million in 2024, then sank by 34.93% to $1.2 million in 2025, then tumbled by 214.27% to -$1.4 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.4 million, $1.2 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.